Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Loonyon Jun 25, 2023 12:28pm
562 Views
Post# 35513597

How the mob steals from shareholders!!!

How the mob steals from shareholders!!!https://www.lapresse.ca/affaires/2023-02-18/remboursement-de-la-corruption/accurso-propose-de-payer-48-millions-aux-gouvernements.php
Placement vapor dans une biotech

Le plan du contrleur Raymond Chabot, dpos le 6 fvrier, permet d’apprendre qu’une des entreprises d’Accurso, 9054-9999 Qubec inc., est actionnaire d’une petite socit biopharmaceutique de Laval, Liminal Biosciences inc.

Inscrite la Bourse amricaine de socits technologiques NASDAQ, elle se spcialise dans « le dveloppement de nouvelles petites molcules thrapeutiques distinctives pour les maladies inflammatoires, fibrotiques et mtaboliques », selon son site internet.

Liminal BioSciences Inc
NASDAQ: LMNL
Follow
6.48 USD -1,019.66 (-99.37%)all time
Jun 23, 4:00p.m. EDT • Disclaimer
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse